\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ patient\\ is\\ currently\\ being\\ followed\\ by\\ rheumatology\\.\ \(0\)\
\-\ foot\\:\\ osteoarthritis\\ of\\ the\\ first\\ mtp\\ is\\ demonstrated\\.\\ \\ there\\ is\\ ossification\\ of\\ the\\ achilles\\ tendon\\.\ \(0\)\
\-\ wrist\\:\\ calcification\\ of\\ the\\ tfcc\\ and\\ chondral\\ cartilage\\ of\\ the\\ wrist\\.\ \(0\)\
\-\ knee\\:\\ \\ chondrocalcinosis\\ is\\ present\\.\ \(0\)\
\-\ calcium\\ pyrophosphate\\ dihydrate\\ \\(cppd\\)\\ crystal\\ deposition\\ disease\ \(0\)\
\-\ gout\ \(75\)\
\-\ primary\\ hyperparathyroidism\ \(7\)\
\-\ hemochromatosis\ \(13\)\
\-\ knee\\ pain\\ in\\ an\\ elderly\\ male\\.\ \(0\)\
\-\ calcium\\ pyrophosphate\\ dihydrate\\ crystal\\ deposition\\ disease\\ is\\ characterized\\ by\\ calcification\\ in\\ and\\ around\\ joints\\ and\\ by\\ structural\\ changes\\ in\\ the\\ joints\\.\\ \\ this\\ is\\ pyrophosphate\\ arthropathy\\.\\ non\\-weight\\ bearing\\ joints\\ such\\ as\\ radiocarpal\\,\\ metacarpophalangeal\\ joints\\,\\ glenohumeral\\ joints\\ and\\ the\\ elbow\\ are\\ affected\\.\\ \\ patellofemoral\\ and\\ radiocarpal\\ joint\\ space\\ narrowing\\ may\\ be\\ seen\\.\\ \\ \ \(0\)\
\-\ subchondral\\ cysts\\ are\\ one\\ of\\ the\\ hallmarks\\ of\\ this\\ disease\\.\\ \\ cysts\\ may\\ form\\ before\\ cartilage\\ loss\\ presents\\.\\ \\ cysts\\ are\\ larger\\ and\\ more\\ numerous\\ that\\ in\\ osteoarthritis\\.\\ \\ \ \(0\)\
\-\ cppd\\ in\\ fibrocartilage\\ is\\ most\\ common\\ in\\ the\\ menisci\\ of\\ the\\ knee\\,\\ triangular\\ fibrocartilage\\ of\\ the\\ wrist\\,\\ acetabular\\ labrum\\,\\ pubic\\ symphysis\\ and\\ annulus\\ fibrosis\\ of\\ the\\ intervertebral\\ disk\\.\\ \\ \ \(0\)\
\-\ synovial\\ calcifications\\ are\\ common\\ in\\ the\\ wrist\\,\\ knee\\,\\ mcp\\ and\\ mtp\\ joints\\.\\ \\ capsular\\ calcification\\ is\\ most\\ commonly\\ observed\\ in\\ the\\ elbow\\,\\ glenohumeral\\,\\ mtp\\,\\ and\\ mcp\\ joints\\.\\ \\ \ \(0\)\
\-\ tendon\\ calcifications\\ are\\ present\\ in\\ as\\ much\\ as\\ 13\\%\\ of\\ patients\\.\\ \\ the\\ most\\ frequently\\ affected\\ sites\\ are\\ the\\ supraspinatus\\,\\ triceps\\,\\ quadriceps\\,\\ gastrocnemius\\ and\\ achilles\\ tendons\\.\ \(0\)\
\-\ the\\ lunotriquetral\\ ligament\\ is\\ more\\ common\\ than\\ the\\ triangular\\ fibrocartilage\\ to\\ be\\ calcified\\.\\ \\ degenerative\\ tears\\ of\\ the\\ triangular\\ fibrocartilage\\ and\\ degeneration\\ of\\ the\\ articular\\ cartilage\\ of\\ the\\ lunate\\ are\\ associated\\ with\\ cppd\\ crystal\\ deposits\\.\ \(0\)\
\-\ the\\ knee\\ is\\ most\\ commonly\\ involved\\ and\\ affects\\ the\\ medial\\ femortibial\\ compartment\\.\\ \\ isolated\\ patellofemoral\\ narrowing\\ should\\ suggest\\ underlying\\ cppd\\ crystal\\ deposition\\ disease\\ in\\ an\\ older\\ patient\\,\\ even\\ without\\ joint\\ calcification\\.\\ \\ wedge\\ shaped\\ meniscal\\ calcification\\ is\\ more\\ frequent\\ than\\ linear\\ calcification\\ \\(lateral\\ more\\ often\\ than\\ medial\\)\\.\ \(0\)\
\-\ the\\ talocalcaneonavicular\\ joint\\ may\\ be\\ selectively\\ affected\\ \\ the\\ achilles\\ tendon\\ and\\ plantar\\ fascia\\ may\\ calcify\\.\ \(0\)\
\-\ steinbach\\,\\ ls\\ \\"calcium\\ pyrophosphate\\ dihydrate\\ and\\ calcium\\ hydroxyapatite\\ crystal\\ deposition\\ diseases\\:\\ imaging\\ perspectives\\"\\.\\ \\ radiologic\\ clinics\\ of\\ north\\ america\\ 42\\ \\(2004\\)\\ 185\\-205\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ crystal\\:\\ 0\\.07698129828587971\ \(0\)\
\-\ joints\\:\\ 0\\.0724119193616309\ \(0\)\
\-\ fibrocartilage\\:\\ 0\\.06535937665980147\ \(0\)\
\-\ pyrophosphate\\:\\ 0\\.06106874059516481\ \(0\)\
\-\ cppd\\:\\ 0\\.056947420311971975\ \(0\)\
\-\ mtp\\:\\ 0\\.05093351707276292\ \(0\)\
\-\ dihydrate\\:\\ 0\\.05093351707276292\ \(0\)\
\-\ deposition\\:\\ 0\\.05050229794848622\ \(0\)\
\-\ calcification\\:\\ 0\\.04923469235646236\ \(0\)\
\-\ calcium\\:\\ 0\\.044241158050125524\ \(0\)\
\-\ wrist\\:\\ 0\\.04177760818530069\ \(0\)\
\-\ knee\\:\\ 0\\.040985327017993074\ \(0\)\
\-\ triangular\\:\\ 0\\.03940770493854317\ \(0\)\
\-\ achilles\\:\\ 0\\.036476275545955485\ \(0\)\
\-\ cartilage\\:\\ 0\\.035286274376979974\ \(0\)\
\-\ radiocarpal\\:\\ 0\\.03349530039247882\ \(0\)\
\-\ patellofemoral\\:\\ 0\\.03165240783021313\ \(0\)\
\-\ tendon\\:\\ 0\\.03164448164019204\ \(0\)\
\-\ glenohumeral\\:\\ 0\\.0313499823601605\ \(0\)\
\-\ mcp\\:\\ 0\\.02940434860288368\ \(0\)\
\-\ affected\\:\\ 0\\.02934543342499796\ \(0\)\
\-\ cysts\\:\\ 0\\.02656712922882037\ \(0\)\
\-\ elbow\\:\\ 0\\.023326979770911346\ \(0\)\
\-\ femortibial\\:\\ 0\\.02332147731208068\ \(0\)\
\-\ steinbach\\:\\ 0\\.02332147731208068\ \(0\)\
\-\ perspectives\\:\\ 0\\.02332147731208068\ \(0\)\
\-\ 185\\-205\\:\\ 0\\.02332147731208068\ \(0\)\
\-\ more\\:\\ 0\\.022615622320763664\ \(0\)\
\-\ osteoarthritis\\:\\ 0\\.022438134632079974\ \(0\)\
\-\ joint\\:\\ 0\\.02193197821461969\ \(0\)\
\-\ are\\:\\ 0\\.02157173838017781\ \(0\)\
\-\ talocalcaneonavicular\\:\\ 0\\.021487754612186646\ \(0\)\
\-\ most\\:\\ 0\\.020876562346328845\ \(0\)\
\-\ ls\\:\\ 0\\.020415095596027482\ \(0\)\
\-\ may\\:\\ 0\\.019834162633842578\ \(0\)\
\-\ selectively\\:\\ 0\\.019654031912292612\ \(0\)\
\-\ hallmarks\\:\\ 0\\.019063705056964014\ \(0\)\
\-\ narrowing\\:\\ 0\\.018129347588095222\ \(0\)\
\-\ than\\:\\ 0\\.017770229007287888\ \(0\)\
\-\ common\\:\\ 0\\.01774815247584442\ \(0\)\
\-\ tfcc\\:\\ 0\\.01750871387997428\ \(0\)\
\-\ metacarpophalangeal\\:\\ 0\\.01750871387997428\ \(0\)\
\-\ lunotriquetral\\:\\ 0\\.01722998235706998\ \(0\)\
\-\ commonly\\:\\ 0\\.017061012928336727\ \(0\)\
\-\ hydroxyapatite\\:\\ 0\\.016977839024254305\ \(0\)\
\-\ calcifications\\:\\ 0\\.016810390236152127\ \(0\)\
\-\ chondral\\:\\ 0\\.01674765019623941\ \(0\)\
\-\ rheumatology\\:\\ 0\\.016535897001335877\ \(0\)\
\-\ clinics\\:\\ 0\\.016535897001335877\ \(0\)\
\-\ is\\:\\ 0\\.016362959159343868\ \(0\)\
\-\ non\\-weight\\:\\ 0\\.01633984416495037\ \(0\)\
\-\ symphysis\\:\\ 0\\.015826203915106564\ \(0\)\
\-\ hemochromatosis\\:\\ 0\\.01567499118008025\ \(0\)\
\-\ menisci\\:\\ 0\\.01567499118008025\ \(0\)\
\-\ calcify\\:\\ 0\\.01567499118008025\ \(0\)\
\-\ capsular\\:\\ 0\\.015531956203174756\ \(0\)\
\-\ chondrocalcinosis\\:\\ 0\\.015267185148791202\ \(0\)\
\-\ america\\:\\ 0\\.015267185148791202\ \(0\)\
\-\ gastrocnemius\\:\\ 0\\.01514411632436027\ \(0\)\
\-\ compartment\\:\\ 0\\.01514411632436027\ \(0\)\
\-\ fascia\\:\\ 0\\.015026519068881874\ \(0\)\
\-\ north\\:\\ 0\\.015026519068881874\ \(0\)\
\-\ acetabular\\:\\ 0\\.014805932801847346\ \(0\)\
\-\ annulus\\:\\ 0\\.014805932801847346\ \(0\)\
\-\ disease\\:\\ 0\\.014780291441436022\ \(0\)\
\-\ labrum\\:\\ 0\\.01470217430144184\ \(0\)\
\-\ quadriceps\\:\\ 0\\.014602332163921082\ \(0\)\
\-\ deposits\\:\\ 0\\.014602332163921082\ \(0\)\
\-\ pubic\\:\\ 0\\.014506121465056332\ \(0\)\
\-\ medial\\:\\ 0\\.014461902188307153\ \(0\)\
\-\ structural\\:\\ 0\\.014413287285661438\ \(0\)\
\-\ wedge\\:\\ 0\\.014413287285661438\ \(0\)\
\-\ intervertebral\\:\\ 0\\.013915794609727736\ \(0\)\
\-\ tendons\\:\\ 0\\.013768784421487495\ \(0\)\
\-\ lunate\\:\\ 0\\.013768784421487495\ \(0\)\
\-\ supraspinatus\\:\\ 0\\.013562536957281908\ \(0\)\
\-\ tears\\:\\ 0\\.013371212455748505\ \(0\)\
\-\ elderly\\:\\ 0\\.013310393624466234\ \(0\)\
\-\ triceps\\:\\ 0\\.013192796368987838\ \(0\)\
\-\ bearing\\:\\ 0\\.013080204796451342\ \(0\)\
\-\ meniscal\\:\\ 0\\.013025656417608125\ \(0\)\
\-\ synovial\\:\\ 0\\.012972210101953312\ \(0\)\
\-\ plantar\\:\\ 0\\.012919822199053365\ \(0\)\
\-\ affects\\:\\ 0\\.012868451601547804\ \(0\)\
\-\ arthropathy\\:\\ 0\\.012720066769137638\ \(0\)\
\-\ gout\\:\\ 0\\.012672398765162298\ \(0\)\
\-\ sites\\:\\ 0\\.01231914111271647\ \(0\)\
\-\ disk\\:\\ 0\\.012237734608307068\ \(0\)\
\-\ 2004\\:\\ 0\\.012158758515318495\ \(0\)\
\-\ articular\\:\\ 0\\.012120137352828674\ \(0\)\
\-\ \\:\\:\\ 0\\.01196058006339328\ \(0\)\
\-\ hyperparathyroidism\\:\\ 0\\.011864510803386685\ \(0\)\
\-\ subchondral\\:\\ 0\\.011864510803386685\ \(0\)\
\-\ isolated\\:\\ 0\\.011762091458993325\ \(0\)\
\-\ radiologic\\:\\ 0\\.011762091458993325\ \(0\)\
\-\ shaped\\:\\ 0\\.011506905569608239\ \(0\)\
\-\ ossification\\:\\ 0\\.0114766709245722\ \(0\)\
\-\ degeneration\\:\\ 0\\.0114766709245722\ \(0\)\
\-\ 42\\:\\ 0\\.011446777921254916\ \(0\)\
\-\ older\\:\\ 0\\.011387986554099599\ \(0\)\
\-\ diseases\\:\\ 0\\.011387986554099599\ \(0\)\
\-\ frequent\\:\\ 0\\.011302178946287022\ \(0\)\
\-\ by\\:\\ 0\\.011292626216229165\ \(0\)\
\-\ characterized\\:\\ 0\\.011246482096557308\ \(0\)\
\-\ in\\:\\ 0\\.011148074871435315\ \(0\)\
\-\ larger\\:\\ 0\\.010886344069243601\ \(0\)\
\-\ observed\\:\\ 0\\.010838676065268261\ \(0\)\
\-\ \\,\\:\\ 0\\.010742462917352672\ \(0\)\
\-\ form\\:\\ 0\\.010569409678204923\ \(0\)\
\-\ much\\:\\ 0\\.010464830739695306\ \(0\)\
\-\ be\\:\\ 0\\.010458386693205786\ \(0\)\
\-\ ligament\\:\\ 0\\.010384045755938476\ \(0\)\
\-\ as\\:\\ 0\\.010258551634080378\ \(0\)\
\-\ degenerative\\:\\ 0\\.010248349209939667\ \(0\)\
\-\ present\\:\\ 0\\.010211686528739052\ \(0\)\
\-\ 13\\:\\ 0\\.010210823720542956\ \(0\)\
\-\ numerous\\:\\ 0\\.010137332810206777\ \(0\)\
\-\ fibrosis\\:\\ 0\\.010065828385900111\ \(0\)\
\-\ even\\:\\ 0\\.010065828385900111\ \(0\)\
\-\ frequently\\:\\ 0\\.009797700094206229\ \(0\)\
\-\ calcified\\:\\ 0\\.009703767055960436\ \(0\)\
\-\ underlying\\:\\ 0\\.00968843076579026\ \(0\)\
\-\ suggest\\:\\ 0\\.009627959501038806\ \(0\)\
\-\ linear\\:\\ 0\\.009583496225069545\ \(0\)\
\-\ before\\:\\ 0\\.009568839663229292\ \(0\)\
\-\ involved\\:\\ 0\\.009482565627280188\ \(0\)\
\-\ around\\:\\ 0\\.009412759396663271\ \(0\)\
\-\ foot\\:\\ 0\\.009344747870974893\ \(0\)\
\-\ currently\\:\\ 0\\.008958129087333485\ \(0\)\
\-\ the\\:\\ 0\\.008777732362134971\ \(0\)\
\-\ n\\/a\\:\\ 0\\.008188377373965836\ \(0\)\
\-\ being\\:\\ 0\\.007877745970371847\ \(0\)\
\-\ first\\:\\ 0\\.0075859350126609845\ \(0\)\
\-\ followed\\:\\ 0\\.007579036696769236\ \(0\)\
\-\ space\\:\\ 0\\.007477664039885277\ \(0\)\
\-\ often\\:\\ 0\\.007212892985501726\ \(0\)\
\-\ should\\:\\ 0\\.007206900904467724\ \(0\)\
\-\ such\\:\\ 0\\.007067017962541937\ \(0\)\
\-\ primary\\:\\ 0\\.006696783764274329\ \(0\)\
\-\ and\\:\\ 0\\.006667000212304387\ \(0\)\
\-\ demonstrated\\:\\ 0\\.006633386196976104\ \(0\)\
\-\ loss\\:\\ 0\\.006562074530339787\ \(0\)\
\-\ changes\\:\\ 0\\.0064789629000927525\ \(0\)\
\-\ an\\:\\ 0\\.006252195049125555\ \(0\)\
\-\ one\\:\\ 0\\.006126273500821809\ \(0\)\
\-\ patients\\:\\ 0\\.0058507264533492745\ \(0\)\
\-\ \\(\\:\\ 0\\.005733029573363972\ \(0\)\
\-\ \\)\\:\\ 0\\.005662997556454802\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.00555591279796777\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.00544907275656678\ \(0\)\
\-\ associated\\:\\ 0\\.005334557042083867\ \(0\)\
\-\ without\\:\\ 0\\.005322786154386667\ \(0\)\
\-\ imaging\\:\\ 0\\.005296491599088896\ \(0\)\
\-\ \\%\\:\\ 0\\.00527333606705293\ \(0\)\
\-\ this\\:\\ 0\\.005085382081027158\ \(0\)\
\-\ lateral\\:\\ 0\\.004885365200064948\ \(0\)\
\-\ presents\\:\\ 0\\.004618106601872819\ \(0\)\
\-\ patient\\:\\ 0\\.004532232438711047\ \(0\)\
\-\ seen\\:\\ 0\\.004467268822930397\ \(0\)\
\-\ of\\:\\ 0\\.004314955585110683\ \(0\)\
\-\ male\\:\\ 0\\.0040878453383266485\ \(0\)\
\-\ that\\:\\ 0\\.003904710922113289\ \(0\)\
\-\ there\\:\\ 0\\.0033643268689549964\ \(0\)\
\-\ pain\\:\\ 0\\.0027608681680707267\ \(0\)\
\-\ \\.\\:\\ 0\\.002441767033150802\ \(0\)\
\-\ to\\:\\ 0\\.0011298098106957309\ \(0\)\
\-\ with\\:\\ 0\\.00030953485738066064\ \(0\)\
